REG - AIM - Cancellation - Silence Therapeutics Plc

Silence TherapeuticsAnnouncement

30/11/2021 08:05

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20211130:nRSd9414Ta&default-theme=true

RNS Number : 9414T  AIM  30 November 2021

NOTICE

 

30/11/2021 - 07:00

 

NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM

 

Pursuant to AIM Rule 41 the following securities have been cancelled from
trading on AIM with effect from the time and date of this notice.

 

 SILENCE THERAPEUTICS PLC
 213800SSURRJBX85SQ91
 ORDINARY SHARES OF 5P EACH, FULLY PAID  (B9GTXM6)(GB00B9GTXM62)  SILE THER / PAR VTG FPD 0.05

 

If you have any queries or require further information, please contact the
company's nominated adviser.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  AMODKCBDOBDDCDB